Activity of pyrazinamide in the guinea pig model of tuberculosis.
作者信息
Mitchison Denis A
出版信息
Antimicrob Agents Chemother. 2010 Dec;54(12):5420. doi: 10.1128/AAC.00928-10.
Abstract
摘要
相似文献
1
Activity of pyrazinamide in the guinea pig model of tuberculosis.吡嗪酰胺在豚鼠结核病模型中的活性。
Antimicrob Agents Chemother. 2010 Dec;54(12):5420. doi: 10.1128/AAC.00928-10.
2
Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.结核分枝杆菌豚鼠模型中标准化疗的评价。
Antimicrob Agents Chemother. 2010 May;54(5):1820-33. doi: 10.1128/AAC.01521-09. Epub 2010 Feb 16.
3
[Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].[在BACTEC - 960细菌分析仪上测定结核分枝杆菌对吡嗪酰胺的敏感性]
Probl Tuberk Bolezn Legk. 2003(7):40-2.
4
Bacteriologic basis of short-course chemotherapy for tuberculosis.结核病短程化疗的细菌学基础
Clin Chest Med. 1980 May;1(2):231-41.
5
Basic mechanisms of chemotherapy.
Chest. 1979 Dec;76(6 Suppl):771-81. doi: 10.1378/chest.76.6_supplement.771.
6
Treatment of tuberculosis. The Mitchell lecture 1979.结核病的治疗。1979年米切尔讲座
J R Coll Physicians Lond. 1980 Apr;14(2):91-5, 98-9.
7
Delamanid Kills Dormant Mycobacteria and in a Guinea Pig Model of Tuberculosis.地拉米定可杀死休眠分枝杆菌，并在豚鼠结核病模型中发挥作用。
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.02402-16. Print 2017 Jun.
8
Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.甲硝唑对感染结核分枝杆菌的豚鼠缺乏抗菌活性。
Antimicrob Agents Chemother. 2008 Nov;52(11):4137-40. doi: 10.1128/AAC.00196-08. Epub 2008 Aug 11.
9
Experimental ocular tuberculosis in guinea pigs.豚鼠实验性眼结核
Arch Ophthalmol. 2009 Sep;127(9):1162-6. doi: 10.1001/archophthalmol.2009.220.
10
[Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].[第二阶段使用和不使用吡嗪酰胺的结核病短期治疗（TA-80）]
Rev Med Chil. 1983 Jul;111(7):750-4.
引用本文的文献
1
Impact of immunopathology on the antituberculous activity of pyrazinamide.免疫病理学对吡嗪酰胺抗结核活性的影响。
J Exp Med. 2018 Aug 6;215(8):1975-1986. doi: 10.1084/jem.20180518. Epub 2018 Jul 17.
本文引用的文献
1
Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.结核分枝杆菌豚鼠模型中标准化疗的评价。
Antimicrob Agents Chemother. 2010 May;54(5):1820-33. doi: 10.1128/AAC.01521-09. Epub 2010 Feb 16.
2
Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.吡嗪酰胺在一种新型结核病体外杀菌模型中的药代动力学-药效学：一种快速评估新型抗结核药物的范例
Antimicrob Agents Chemother. 2009 Aug;53(8):3197-204. doi: 10.1128/AAC.01681-08. Epub 2009 May 18.
3
Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis.莫西沙星和加替沙星在结核分枝杆菌持续感染酸性模型中的研究
J Chemother. 2006 Dec;18(6):617-23. doi: 10.1179/joc.2006.18.6.617.
4
Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.吡嗪酰胺在潜伏性和耐利福平结核分枝杆菌模型中的杀菌作用
Int J Tuberc Lung Dis. 2006 Mar;10(3):317-22.
5
Antimicrobial therapy of tuberculosis: justification for currently recommended treatment regimens.
Semin Respir Crit Care Med. 2004 Jun;25(3):307-15. doi: 10.1055/s-2004-829503.
6
[Activity of pyrazinamide against experimental tuberculosis].[吡嗪酰胺对实验性结核病的活性]
Ann Inst Pasteur (Paris). 1958 Jun;94(6):694-708.
7
The antituberculous activity of pyrazinamide in vitro and in the guinea pig.吡嗪酰胺在体外及豚鼠体内的抗结核活性。
Am Rev Tuberc. 1954 Aug;70(2):367-9. doi: 10.1164/art.1954.70.2.367.
8
Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.抗结核药物在最初14天内的杀菌和灭菌活性。
Am J Respir Crit Care Med. 2003 May 15;167(10):1348-54. doi: 10.1164/rccm.200210-1125OC. Epub 2003 Jan 6.
9
Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet. 1972 May 20;1(7760):1079-85.
Zotero 插件